Chemoimmunotherapy Linked to HNSCC Response

• by Andrea Surnit

• June 5, 2026

Novel Immunotherapy Agents in Early-Phase Trials for Head and Neck Cancer

• by Harold Nathan Tan, Bettzy Stephen, Oriol Mirallas, Mohamed H. Derbala, Israa Salih, Lilibeth Castillo, Yali Yang, Hung Le, Lei Kang, Heather Lin, Joann Lim, Ecaterina E. Dumbrava, Timothy A. Yap, Jordi Rodón, Sarina A. Piha-Paul, Siqing Fu, Stéphane Champiat, Neal Akhave, Renata Ferrarotto, David S. Hong, Funda Meric-Bernstam, Faye Johnson, Aung Naing

• July 16, 2026

Top 10 Growing Metro Areas With Active HPSAs

These 10 metropolitan areas reported population gains and active federal shortage area designations identified in census and health care workforce data.

• by Conexiant News Staff

• June 30, 2026

• 3 min

Perioperative immunotherapy in resectable HNSCC: biological rationale to practical multidisciplinary implementation

• by Michel Bila, Vincent Vander Poorten, Jeroen Meulemans, Wouter Huvenne, Wouter De Vos, Robin Willaert, Joke De Ceulaer, Paul M. Clement

• May 15, 2026